Chia‐Yang Hsu
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 56
- Liver Disease and Transplantation 27
- Hepatitis C virus research 5
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment 55
- Hepatitis B Virus Studies 6
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 14
- Surgery top 5%
- Cholangiocarcinoma and Gallbladder Cancer Studies 17
- Organ Transplantation Techniques and Outcomes 4
- Oncology top 10%
- Co-authors
- Teh‐Ia HuoYi‐Hsiang HuangCheng‐Yuan HsiaHan‐Chieh LinChien‐Wei SuPo‐Hong LiuYun-Hsuan LeeYi‐You Chiou
- Partner nations
- TaiwanUnited StatesUnited Kingdom
In The Last Decade
Chia‐Yang Hsu
67 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 79
- Hepatology 1.8k
- Epidemiology 1.3k
- Cancer Research 395
- Surgery 606
- Oncology 336
Countries citing papers authored by Chia‐Yang Hsu
This map shows the geographic impact of Chia‐Yang Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Yang Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Yang Hsu more than expected).
Fields of papers citing papers by Chia‐Yang Hsu
This network shows the impact of papers produced by Chia‐Yang Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Yang Hsu. The network helps show where Chia‐Yang Hsu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chia‐Yang Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 16 | |
| 2 | 2021 | 29 | |
| 3 | 2020 | 2 | |
| 4 | 2020 | 13 | |
| 5 | 2020 | 31 | |
| 6 | 2020 | 10 | |
| 7 | 2020 | 5 | |
| 8 | 2019 | 11 | |
| 9 | 2018 | 27 | |
| 10 | 2018 | 32 | |
| 11 | 2018 | 14 | |
| 12 | 2018 | 19 | |
| 13 | 2018 | 37 | |
| 14 | 2017 | 33 | |
| 15 | 2017 | 9 | |
| 16 | 2015 | 12 | |
| 17 | 2014 | 20 | |
| 18 | 2014 | 30 | |
| 19 | 2014 | 16 | |
| 20 | 2012 | 22 |
About Chia‐Yang Hsu
Chia‐Yang Hsu is a scholar working on Hepatology, Epidemiology and Cancer Research, having authored 67 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (56 papers), Liver Disease Diagnosis and Treatment (55 papers), Liver Disease and Transplantation (27 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers), Cancer, Lipids, and Metabolism (14 papers), Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (5 papers) and Organ Transplantation Techniques and Outcomes (4 papers). The work is most often cited by research in Hepatology (1.8k citations), Epidemiology (1.3k citations) and Cancer Research (395 citations). Chia‐Yang Hsu has collaborated with scholars based in Taiwan, United States and United Kingdom. Frequent co-authors include Teh‐Ia Huo, Yi‐Hsiang Huang, Cheng‐Yuan Hsia, Han‐Chieh Lin, Chien‐Wei Su, Po‐Hong Liu, Yun-Hsuan Lee, Yi‐You Chiou, Fa‐Yauh Lee and Rheun‐Chuan Lee. Their work appears in journals such as Gastroenterology, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.